Twist Bioscience Corp - Common stock, $0.00001 par value per share (TWST)

Historical Holders from Q4 2018 to Q3 2025

Symbol
TWST on Nasdaq
CUSIP
90184D100
Type / Class
Equity / Common stock, $0.00001 par value per share
Shares outstanding
60.4M
All holders as of September 30, 2025
Q3 2025
Total 13F shares, excl. options
73.8M
Holdings value
$2.08B
% of all portfolios
0.002%
Grand Portfolio weight change
+0%
Number of holders
231
Number of buys
128
Number of sells
-102
Average Value change %
+0%
Average buys %
+0.001%
Average sells %
-0.001%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Twist Bioscience Corp - Common stock, $0.00001 par value per share (TWST)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Artisan Partners Limited Partnership 10.6% +27.5% $180M $38M 6.41M +26.7% Artisan Partners Asset Management Inc. Sep 30, 2025
ARK Investment Management LLC 10.7% +17.2% $231M $37.1M 6.38M +19.1% ARK Investment Management LLC Feb 28, 2025
BlackRock, Inc. 8.3% $178M 4.93M BlackRock, Inc. Mar 31, 2025
EdgePoint Investment Group Inc. 6.76% $115M 4.08M EdgePoint Investment Group Inc. Sep 30, 2025
WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC 6.4% +28% $138M $31M 3.81M +29.1% WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC Mar 31, 2025
STATE STREET CORP 5.1% +20% $86.9M $15.3M 3.09M +21.4% STATE STREET CORPORATION Sep 30, 2025
Invesco Ltd. 3.9% $88.5M 2.35M Invesco Ltd. Jun 30, 2025

Institutional Holders of Twist Bioscience Corp - Common stock, $0.00001 par value per share (TWST)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 73.8M $2.08B +$57.8M $28.14 231
2025 Q2 71.1M $2.62B +$58.4M $36.79 240
2025 Q1 69.5M $2.73B +$98.7M $39.26 260
2024 Q4 66.4M $3.08B +$14.7M $46.47 243
2024 Q3 65.9M $2.98B -$19.2M $45.18 239
2024 Q2 66M $3.25B +$42.2M $49.28 258
2024 Q1 66.8M $2.29B +$23.1M $34.31 229
2023 Q4 22.7K $835K -$325K $36.86 1
2023 Q3 66M $1.34B -$31.2M $20.26 188
2023 Q2 67.7M $1.39B +$101M $20.46 182
2023 Q1 63.5M $956M +$12.8M $15.08 194
2022 Q4 60.7M $1.44B +$141M $23.81 185
2022 Q3 54.7M $1.92M -$67.5M $0.04 196
2022 Q2 53.4M $1.85B -$79.1M $34.96 179
2022 Q1 59.1M $2.91B +$350M $49.38 191
2021 Q4 51.1M $3.95B +$150M $77.39 218
2021 Q3 48.6M $5.19B +$44.2M $106.97 229
2021 Q2 48.1M $6.4B +$163M $133.25 235
2021 Q1 46.9M $5.81B +$483M $123.86 230
2020 Q4 42.9M $6.06B +$546M $141.29 209
2020 Q3 39.7M $3.02B +$219M $75.97 189
2020 Q2 33.4M $1.51B +$271M $45.30 139
2020 Q1 30.3M $928M +$329M $30.58 113
2019 Q4 19.6M $412M +$39.7M $21.00 91
2019 Q3 15.6M $372M +$36.2M $23.88 80
2019 Q2 13.8M $400M +$230M $29.01 81
2019 Q1 6M $138M -$1.67M $23.18 46
2018 Q4 6.08M $137M +$137M $23.09 45